Supplemental material
Expert Opinion on Drug Delivery
Volume 17, 2020 - Issue 6
Open access
2,429
Views
6
CrossRef citations to date
0
Altmetric
Original Research
A multicenter, open-label study to evaluate the safe and effective use of a new electromechanical auto-injection device for self-injection of certolizumab pegol
Daljit Tatlaa UCB Pharma, Raleigh, NC, USACorrespondence[email protected]
View further author information
, View further author information
Irina Mountianb UCB Pharma, Brussels, BelgiumView further author information
, Boglarka Szegvarib UCB Pharma, Brussels, BelgiumView further author information
, Brenda VanLunena UCB Pharma, Raleigh, NC, USAView further author information
& Michael Schiffc Department of Rheumatology, University of Colorado School of Medicine, Denver, Colorado, USAView further author information
Pages 855-862
|
Received 10 Dec 2019, Accepted 23 Mar 2020, Published online: 24 Apr 2020
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.